MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Time from Referral to DBS: A Single-Centre Canadian Study

K. Yen, S. Poonja, J. Miyasaki, T. Sankar, A. Shetty, F. Ba (Edmonton, Canada)

Meeting: MDS Virtual Congress 2021

Abstract Number: 1271

Keywords: Deep brain stimulation (DBS)

Category: Surgical Therapy: Parkinson's Disease

Objective: To study the time to deep brain surgery (DBS) for movement disorders and breaking down the time to each step in the DBS process, i.e. consultations with various services and investigations.

Background: Canada has a publicly funded healthcare system, grounded in equity and universality. Canada Health Act emphasizes “reasonable access to medically necessary hospital and physician services”. DBS is an important treatment for Parkinson’s disease, tremor, and dystonia in appropriately selected patients. Timely access to DBS is crucial as disease progression and aging can result in patients missing the therapeutic window. Breaking down the timing of steps from referral to surgery can identify barriers to access and inform strategies to reduce delays in surgical treatment.

Method: A total of 44 DBS patients from January 2015 to February 2020 at the University of Alberta were included. The date of DBS neurologist’s referral to the interdisciplinary DBS team marked the start of the workup (day 0). Time to additional consults and to surgery were analyzed.

Results: Time from initial referral to the DBS neurologist and decision to move forward with formal DBS workup was 205.7+/-156.4 (22-525) days. Reasons for the wide range were multiple, encompassing factors such as patient availability, reluctance to undergo neurosurgery, and the need for an additional visit for levodopa challenge. Time to neurosurgical consult was 79.7+/-81.2 days. Time to neuropsychology and psychiatry consult was 149.5+/-95.5 and 146.3+/-100.3 days respectively. Time to physical/occupational therapy functional assessment was 141.7+113.3 days. Screening MRI completion took 102.7+/-100.2 days. Average time to consent for surgery from initial referral was 242.1+/-94.9 days. Total time from initial decision for DBS workup to surgery was 381.6+/-119.9 days.

Conclusion: This single center study analyzed the time breakdown required for each step of the process, from referral to the DBS neurologist to surgery. Utilization of DBS in Canada is low (10 cases/1,000,000/year) which has limited large-scale studies, including analyzing the process and time to surgery. Time of more than one year from initiation of the process to surgery is not optimal in a publicly funded system for these progressive/degenerative diseases. Future studies are needed to evaluate the barriers to receiving DBS to optimize patient care.

To cite this abstract in AMA style:

K. Yen, S. Poonja, J. Miyasaki, T. Sankar, A. Shetty, F. Ba. Time from Referral to DBS: A Single-Centre Canadian Study [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/time-from-referral-to-dbs-a-single-centre-canadian-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/time-from-referral-to-dbs-a-single-centre-canadian-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley